CON: Patients with Recurrent Ovarian Carcinoma Should Not Be Treated with Antiangiogenic Agents in Combination with Chemotherapy


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles